At Beyond Cancer?, we’re focused on harnessing the power of ultra-high-concentration nitric oxide to engage the immune system and prevent solid tumor metastases and relapse with our proprietary technology. It’s an innovative, targeted treatment approach with immunogenic results.
Beyond Cancer, Ltd.的外部链接
An action-packed #ASCO24!
During the @ASCO24 Annual Meeting, Beyond Cancer presented first-in-class clinical data with observed early biologic responses and a clinical resolution of radiation dermatitis from the ongoing Phase 1a study.?The Company also announced the design and regulatory filing of the Phase 1b protocol of UNO in combination with anti-PD-1 antibody therapy. Learn more: https://lnkd.in/gXyCNpp8 hashtag #immunotherapy #ASCO24 #Immunooncology
During the @ASCO24 Annual Meeting, Beyond Cancer presented first-in-class clinical data with observed early biologic responses and a clinical resolution of radiation dermatitis from the ongoing Phase 1a study.?The Company also announced the design and regulatory filing of the Phase 1b protocol of UNO in combination with anti-PD-1 antibody therapy. Learn more: https://lnkd.in/gXyCNpp8 hashtag #immunotherapy #ASCO24 #Immunooncology
We look forward to meeting friends and colleagues in Chicago to discuss our latest data for treating solid tumors.?We will be hosting an evening event at the Hyatt McCormick Place in Chicago, IL, on Friday, May 31, 2024.?Please RSVP to [email protected] for more details.?? #immunotherapy #cancerresearch #cancer